WARNEX RES INC has a total of 30 patent applications. Its first patent ever was published in 2002. It filed its patents most often in Canada, Australia and EPO (European Patent Office). Its main competitors in its focus markets biotechnology, organic fine chemistry and environmental technology are GENEOHM SCIENCES CANADA INC, UPSTATE BIOTECH INC and KIM CHEOL MIN.
# | Country | Total Patents | |
---|---|---|---|
#1 | Canada | 8 | |
#2 | Australia | 7 | |
#3 | EPO (European Patent Office) | 7 | |
#4 | WIPO (World Intellectual Property Organization) | 7 | |
#5 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Organic fine chemistry | |
#3 | Environmental technology |
# | Technology | |
---|---|---|
#1 | Measuring microorganism processes | |
#2 | Peptides | |
#3 | Sugars | |
#4 | Climate change adaptation technologies |
# | Name | Total Patents |
---|---|---|
#1 | Plante Daniel | 23 |
#2 | Ubalijoro Eliane | 21 |
#3 | Hebert Alexandre | 11 |
#4 | Bourassa Nancy | 8 |
#5 | Taylor Gregory | 6 |
#6 | Constant Peggy | 3 |
#7 | Archambault Christian | 3 |
#8 | Dallaire Nancy | 3 |
#9 | Cote Yvan | 3 |
#10 | Dumas Helene | 2 |
Publication | Filing date | Title |
---|---|---|
WO2006029522A1 | Polynucleotides for the detection of campylobacter species | |
AU2005259732A1 | Polynucleotides for the detection of Listeria species | |
CA2566949A1 | Polynucleotides for the detection of escherichia coli o157:h7 and escherichia coli o157:nm verotoxin producers | |
AU2005240684A1 | Polynucleotides for the detection of staphylococcus aureus | |
CA2569085A1 | Polynucleotides for the detection of escherichia coli | |
AU2004317165A1 | Polynucleotides for the detection of escherichia coli O157 | |
AU2004231129A1 | Oligonucleotides for the detection of salmonella species | |
AU2004231124A1 | Polynucleotides for the detection of Listeria monocytogenes | |
CA2442246A1 | System for genomic detection with integrated authentication | |
CA2446206A1 | A molecular tag code for monitoring a product and process using same |